共 49 条
Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma
被引:18
|作者:
Hiromoto, Takafumi
[1
,2
]
Murakami, Takashi
[1
,2
]
Akazawa, Yoichi
[1
,2
]
Sasahara, Noriko
[2
]
Saito, Tsuyoshi
[2
]
Sakamoto, Naoto
[1
]
Mitomi, Hiroyuki
[3
]
Nagahara, Akihito
[1
]
Yao, Takashi
[2
]
机构:
[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo, Japan
[3] Odawara Municipal Hosp, Dept Diagnost Pathol & Lab Med, Odawara, Japan
基金:
日本学术振兴会;
关键词:
BRAF;
KRAS;
mucin-rich variant;
serrated tubulovillous adenoma;
traditional serrated adenoma;
MICROSATELLITE-INSTABILITY;
CARCINOMA SEQUENCE;
BETA-CATENIN;
COLON-CANCER;
EXPRESSION;
DISTINCT;
PATHWAY;
POLYPS;
DIFFERENTIATION;
PROGRESSION;
D O I:
10.1111/his.13643
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
AimsRecently, several morphological variants of traditional serrated adenoma (TSA) of the colorectum have been recognised, and mucin-rich TSA (MR-TSA) and serrated tubulovillous adenoma (S-TVA) were introduced as distinct morphological variants separate from conventional TSA (C-TSA). This aim of this study was to elucidate the immunohistochemical and genetic characteristics of MR-TSAs. Methods and resultsWe performed immunostaining for cytokeratins (CKs) (e.g. CK7 and CK20), mucins (e.g. MUC2, MUC5AC, MUC6, and CD10), -catenin, and MLH1, and direct sequencing of BRAF/KRAS, in 32 MR-TSAs, 35 C-TSAs, and 23 S-TVAs. Immunohistochemically, all studied cases were positive for CK20, whereas few cases were positive for CK7, with no significant differences between the three groups. Regarding mucin-phenotypic expression, all cases were positive for MUC2 but negative for MUC6 and CD10. MUC5AC positivity was found significantly more frequently in MR-TSAs (53%) than in C-TSAs (26%; P = 0.026). Nuclear -catenin expression in MR-TSAs was significantly less frequent than in S-TVAs (P = 0.002). MLH1 nuclear staining was retained in all cases. Genetically, MR-TSAs (75%) more frequently harboured BRAF mutation than C-TSAs (49%; P = 0.044) or S-TVAs (4%; P < 0.001), whereas only two cases (6%) of MR-TSA harboured a KRAS mutation, a frequency that was significantly lower than that in C-TSAs (26%; P = 0.047) or S-TVAs (57%; P < 0.001). ConclusionsMR-TSAs more frequently harboured BRAF mutations than C-TSAs, and had distinct immunohistochemical characteristics. Our findings indicated that MR-TSAs could be important precursors of BRAF-mutated, microsatellite-stable subtypes of colorectal carcinoma.
引用
收藏
页码:444 / 453
页数:10
相关论文